Avadel Pharmaceuticals Plc (NQ: AVDL )
9.090 USD +0.340 (+3.89%) Streaming Delayed Price Updated: 12:07 PM EST, Feb 24, 2021 Add to My Watchlist
All news about Avadel Pharmaceuticals Plc
Avadel Pharmaceuticals to Provide a Company Update and Report Fourth Quarter and Full Year 2020 Financial Results, on March 9th
February 23, 2021
Avadel Pharmaceuticals Appoints Richard Kim as Chief Commercial Officer to Lead the Commercial Launch of Once-Nightly FT218
February 17, 2021
Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference
February 10, 2021
Look Under The Hood: IBB Has 19% Upside
January 07, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
From ETF Channel
Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA
December 16, 2020
Avadel Pharmaceuticals Added to NASDAQ Biotechnology Index
December 15, 2020
In trading on Monday, shares of Avadel Pharmaceuticals PLC (AVDL) crossed above their 200 day moving average of $7.51, changing hands as high as $7.65 per share. Avadel Pharmaceuticals PLC shares are...
Avadel Pharmaceuticals Appoints Dr. Jennifer Gudeman as Vice President of Medical and Clinical Affairs
December 07, 2020
Avadel Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Update on FT218 Development Program
November 09, 2020
Avadel Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 9th
October 26, 2020
4 Sectors Moving Up In Friday's Pre-Market Session
September 25, 2020
Here is the sector-by-sector list of stocks moving higher in today's pre-market session: Healthcare Genfit ...
24 Stocks Moving in Tuesday's Pre-Market Session
September 22, 2020
Gainers DAVIDsTEA Inc. (NASDAQ: DTEA) shares rose 62.6% to $1.41 in pre-market trading after the company reported a narrower Q2 ...
Thinking about buying stock in Avadel Pharmaceuticals, Nikola Corp, Agile Therapeutics, Biocept Inc, or Uber Technologies?
September 21, 2020
From PR Newswire
Avadel to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 17, 2020
Avadel Pharmaceuticals Announces FT218 Leadership Transition
September 14, 2020
Relative Strength Alert For Avadel Pharmaceuticals
September 10, 2020
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
33 Stocks Moving in Friday's Pre-Market Session
September 04, 2020
Gainers PolyMet Mining Corp. (NYSE: PLM) shares rose 29.4% to $3.48 in pre-market trading after a Ramsey County District Court ...
70 Biggest Movers From Yesterday
August 28, 2020
Gainers PEDEVCO Corp. (NYSE: PED) shares climbed 168.7% to close at $2.11 on Thursday after the company delivered an open letter ...
From Motley Fool
Recap: Avadel Pharmaceuticals Q2 Earnings
August 10, 2020
Shares of Avadel Pharmaceuticals (NASDAQ:AVDL) decreased 1.3% in pre-market trading after the company reported Q2 results. Quarterly ...
Avadel Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent Business Update
August 10, 2020
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
August 09, 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive ...
Looking back to 92 days ago, Avadel Pharmaceuticals PLC (AVDL) priced a 11,630,000 share secondary stock offering at $10.75 per share. Buyers in that offering made a considerable investment into the...
Benzinga's Top Upgrades, Downgrades For July 21, 2020
July 21, 2020
Upgrades ForBioNTech SE(NASDAQ: BNTX), B of A Securities upgraded the stock from Neutral to Buy. In the first quarter, ...
Avadel Pharmaceuticals Announces First Patient Dosed in Open-Label Extension/Switch Study of Investigational Once-Nightly FT218 as a Potential Treatment for Excessive Daytime Sleepiness and Cataplexy
July 13, 2020